SA

Shubhangi Agarwal

Active Director Director DIN 08135535
DIN 08135535 First appointment Jun 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 8 active board seats
Past companies 7 historical roles
Total affiliations 15 Since Jun 2015
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 02 Jun 2015
Active appointments 8
Total timeline records 15

Shubhangi Agarwal (DIN 08135535) has 15 recorded board appointments in Indian companies, the first from June 2015, of which 8 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2015
Synokem Lifesciences Private Limited Director · 2025 – present
Current
Agsa And Associates Llp Designated Partner · 2025 – present
Current
R. P. Multimetals Limited Director · 2025 – present
Current
Qualitek Labs Limited Director · 2023 – present
Current
Algoquant Fintech Limited Director · 2022 – present
Current
Synokem Pharmaceuticals Limited Director · 2022 – present
Current
Credent Global Finance Limited Director · 2021 – present
Current
Shigan Quantum Technologies Limited Director · 2021 – present
Current
Abram Food Limited Director · 2024 – 2024
Previous
Prudence Technology Limited Director · 2023 – 2024
Previous
Nitin Lifesciences Limited Director · 2023 – 2025
Previous
As Krishna Associates Limited Additional Director · 2023 – 2023
Previous
Solis-Luna Care Llp Designated Partner · 2021 – 2022
Previous
Apple Art Press Private Limited Additional Director · 2018 – 2018
Previous
Kumon India Education Private Limited Company Secretary · 2015 – 2017
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available